Showing results (21-30 of 153) with videos related to
Sort By:
Pageof 16
Cancer Discovery|September 3, 2017
Fast-TRKing Drug Development for Rare Molecular TargetsAparna R Parikh, Ryan B CorcoranJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
The phase III trial in the era of targeted therapy: unraveling the "go or no go" decisionThomas G Roberts, Thomas J Lynch, Bruce A ChabnerThe Oncologist|March 2, 2019
The Other Opioid Crisis: Just Another Drug Shortage?Tara E Soumerai, Mihir M Kamdar, Bruce A ChabnerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
Pharmacodynamic biomarkers: falling short of the mark?Justin F Gainor, Dan L Longo, Bruce A ChabnerOncotarget|April 21, 2011
Potential therapeutic strategies to overcome acquired resistance to BRAF or MEK inhibitors in BRAF mutant cancersRyan B Corcoran, Jeffrey Settleman, Jeffrey A EngelmanThe Oncologist|December 6, 2003
Breaking bad news: a patient's perspectiveLauren Dias, Bruce A Chabner, Thomas J Lynch, et al.The Oncologist|April 13, 2023
Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World StudyZola Musimar, Mtonga Mpetani, Jeremy S Abramson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
The PI3K pathway as drug target in human cancerKevin D Courtney, Ryan B Corcoran, Jeffrey A EngelmanAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Integrating Biomarkers and Targeted Therapy Into Colorectal Cancer ManagementChristopher H Lieu, Ryan B Corcoran, Michael J OvermanThe Oncologist|June 18, 2002
When does the responsibility of our care end: bereavementRichard T Penson, Kara M Green, Bruce A Chabner, et al.Pageof 16